The Cooper Companies Inc
COO-
Cooper Companies fell 1.4% to $340.0 despite the eyecare company reporting organic revenue growth and higher earnings in its latest quarter.
Revenue in the fiscal fourth quarter increased 9% to $927.1 million from $848.1 million, net income advanced to $84.5 million from $65.6 million, and diluted earnings per share rose to $1.70 from $1.32 a year ago.
The company announced a four-to-one stock split effective February 16, and the board of directors terminated the semi-annual dividend.
The maker of contact lenses and fertility solutions forecasted fiscal 2024 sales to range between $3.809 billion and $3.877 billion, an increase between 6% and 8%, and non-GAAP diluted earnings per share between $13.60 and $14.0.
Dec 8, 2023
|
|
| |
|
| Trading Volume | 168,905 |
|
|
388.02 - 306.88 |
| Market Cap Full | $ 18.4B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | -1.7% | 13% | -1.2% |
| Q2 | - | - | 2.7% | -25% |
| Q3 | - | - | -17.1% | -15.7% |
| Q4 | - | - | 21.3% | 25.2% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -1.4 | -0.3 | - | - | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| 5.5 | -6.4 | 14.4 | 2.2 | -2.6 | 3.2 | 2 | -5.4 | -14.1 | -2 | 8.1 | 12.3 |
| 2022 | |||||||||||
| -5.8 | 2.7 | 2.1 | -13.5 | -2.9 | -10.7 | 4.4 | -12.1 | -8.2 | 3.6 | 15.7 | 4.5 |
| 2021 | |||||||||||
| 0.1 | 6.9 | -1 | 6.8 | -4.2 | 0.7 | 6.6 | 6.7 | -6.3 | -1.3 | -9.7 | 12.3 |
| 2020 | |||||||||||
| 8.5 | -7.9 | -13.6 | 4 | 10.6 | -10.5 | -0.3 | 11.1 | 7.2 | -5.4 | 5.1 | 8.4 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | 1.7 | 1.9 | 42.3 | 1.8 |
| Q2 | 0.8 | 2.6 | 2.4 | 0.2 |
| Q3 | 1.7 | 2 | 12.4 | 1.1 |
| Q4 | 1.7 | 1.3 | 2.1 | 1.6 |
| A | 5.91 | 7.8 | 59.2 | 4.8 |